Intrathecal injection of anti-CXCl1 antibodies has been found to successfully alleviate pain hypersensitivity induced by spinal nerve ligation, and CXCR2 antagonists can definitively terminate CXCl1-induced thermal pain allergy. Here, CXCL1 is linked to Allergy.